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ABSTRACT: The study of stromal-epithelial interactions greatly depends on the ability 
to culture both cell types separately, in order to permit analysis of their interactions under 
defined conditions in reconstitution experiments. Here we report the establishment of ex- 
plant cultures of human prostatic stromal cells and their immunocytochemical characteriza- 
tion. As determined by antibodies to keratin and prostate specific acid phosphatase, only 
small numbers (<5%) of epithelial cells were present in primary cultures; subsequent pas- 
saging further reduced epithelial cell contamination. Antibodies against intermediate fila- 
ment proteins (keratins, vimentin, and desmin) and smooth muscle actin microfilaments 
demonstrated that stromal cells from benign prostatic hyperplasia and prostate carcinoma 
differed in regard to their differentiation markers. Two contrasting phenotypes were iden- 
tified in cultures derived from these two different lesions: One, exhibiting fibroblastic fea- 
tures, was predominant in cultures derived from benign lesions and a second, showing 
varying degrees of smooth muscle differentiation, was more abundant in carcinoma-derived 
cultures. These findings are indicative of a remarkable divergence in the stromal-epithelial 
relationships associated with these pathological conditions and may provide us with a 
potential tool for studying these processes. 
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INTRODUCTION 
Control of cellular proliferation in the prostate in- 
volves a complex interaction of different cell types 
with soluble peptide growth factors, (steroid) hor- 
mones, and constituents of the extracellular matrix. 
The central role of urogenital sinus mesenchyme in 
prostatic ductal morphogenesis, epithelial growth, 
secretory cytodifferentiation, and function has been 
clearly demonstrated. All these androgen-induced ef- 
fects were shown to be mediated by mesenchyme in 
the perinatal period [l]. Further studies on tissue re- 
combinants indicated that stromal-epithelial interac- 
tions have retained their integral role in the adult 
gland [2]. For example, although the androgen recep- 
tor is expressed in prostate epithelium, it is believed 
that the proliferative effect of androgen on epithelium 
in the adult gland is also mediated by the stroma 
[ W .  
Detailed studies require the capability to culture 
epithelial and stromal cells separately in order to per- 
mit reconstitution and analysis of their interactions 
under defined conditions. There have been several 
reports concerning primary culture of murine pros- 
tate epithelial [3] and stromal cells [4-71, while less 
information is available on in vitro models derived 
from human tissue. Although several human pros- 
tatic carcinoma cell lines have become available dur- 
ing the past decade [S-111, and methods were devel- 
oped for primary culture of epithelial cells from 
normal and diseased prostates [12-161, only a few 
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papers have been published of studies using cultured 
human prostatic stromal cells. No studies have been 
conducted so far regarding the characterization of 
these cells, which were tentatively designated as fi- 
broblasts, a nomenclature mainly based on cell mor- 
phology. 
Analysis of cytoskeletal proteins is commonly used 
to assess the differentiation state and embryonic der- 
ivation of many cell types [17-201. The availability of 
antibodies against the intermediate-sized filament 
proteins keratin, vimentin, and desmin has made it 
possible to distinguish between cells with epithelial, 
mesenchymal, and myogenic differentiation [ 18-22]. 
Further characterization of stromal cells can be 
achieved by analysis of actin isoform expression 
[23,24]. These developments have recently led to the 
recognition of a phenotypic heterogeneity among fi- 
broblasts, which might be related to different biologic 
behaviors [24]. Fibroblastic cells have been found to 
express a repertoire of muscle differentiation features 
in physiologic as well as in pathologic conditions [24]. 
Many human epithelial tumors, for instance, are as- 
sociated with the appearance of these so-called myo- 
fibroblasts that are believed to be responsible for the 
frequent, excessive collagen deposition and tissue 
contraction referred to as desmoplasia [25]. 
In this paper we describe the immunocytochemical 
characterization of explant cultures of human pros- 
tatic stromal cells. The presence of residual epithelial 
cells in these cultures was determined using antibod- 
ies to keratin and prostate specific acid phosphatase. 
Subsequently, antibodies against other intermediate 
filament proteins and microfilament smooth muscle 
actin were used to investigate stromal cell cultures 
derived from benign prostatic hyperplasia (BPH) and 
prostate carcinoma (PC) in order to reveal possible 
phenotypic differences. Several cultures were tested 
at subsequent passages in order to monitor potential 
shifts in the expression of these markers during the 
course of subculturing. 
MATERIALS A N D  METHODS 
Human Prostate Tissues 
Wedges of human prostate tissue were dissected 
from benign hyperplastic nodules and prostate can- 
cers obtained by open prostatectomy or transurethral 
resection. After removal of portions of tissue for cul- 
ture, the remaining prostate was fixed in formal de- 
hyde and serially sectioned. The histology of hema- 
toxylin- and eosin-stained sections immediately 
adjacent to tissue removed for culture was reviewed, 
and the findings were correlated with the findings in 
the corresponding cultures. All six prostatic malig- 
nancies were moderately differentiated adenocarci- 
nomas, except for PC 302 and PC 313, which were 
both poorly differentiated carcinomas. Benign pros- 
tatic hyperplasia (BPH) tissue explants showed glan- 
dular hyperplasia in all seven explants, while in sam- 
ples PA 557 and PA 558 an additional fibromuscular 
hyperplasia was noted. 
Tissue Explants and Subcultures 
Tissue specimens were cut into small pieces of ap- 
proximately 2 x 2 mm and placed in 60 mm petri 
dishes (Nunc) containing Earle’s minimum essential 
medium (Gibco Europe, Breda, Netherlands) supple- 
mented with 10% fetal calf serum (Hyclone Labora- 
tories, Logan, Ut), 2 mM glutamine, penicillin (100 
U/ml), and streptomycin (0.1 mg/ml) (all from Gibco 
Europe). Cultures were maintained in a humidified 
incubator at 37°C in 5% CO,/air. Medium was re- 
placed twice a week. For subculture, cells were de- 
tached by trypsinization (0.05% containing 0.02% 
EDTA; Gibco) and split in a 1:3 ratio as soon as mono- 
layers became confluent. 
lmmunostaining Procedures 
Cytospins of cultures were prepared after 
trypsinization. Following the preparation of a single 
cell suspension in culture medium, cells were washed 
and resuspended in phosphate buffered saline (PBS) 
at a final concentration of lo5 cells/ml. Subsequently, 
0.1 ml of this suspension was spun down in a 
cytospin centrifuge for 10 min at 150 g. Cytospin 
preparations were dried in air, fixed in cold acetone 
(-20°C) for 10 min, and left to dry at room tempera- 
ture. In order to preserve cell morphology during the 
procedure, some of the stromal cell strains were 
seeded on object slides and stained in situ after 2-3 
days of culture. Cytospins and fixed cell preparations 
were stored at -20°C until further use. As a control, 
skin fibroblasts (passage number 11-12) were treated 
similarly. Acetone-fixed BPH tissue sections were 
taken as positive controls for the applied antibodies. 
The staining procedure included preincubation 
with blocking serum to reduce nonspecific staining. 
Nonimmune swine serum (DAKO, Denmark) was 
used for polyclonal antibodies, and nonimmune rab- 
bit serum (DAKO) was used for monoclonal antibod- 
ies. Both sera were diluted 10 times in PBS before use. 
Object slides were then incubated with the specified 
antibody (Table I) for 30 min at 37°C at the indicated 
dilution. We used rabbit anti-mouse peroxidase 
(DAKO) as secondary antibodies, diluted 1/100 and 
containing 2% nonimmune rabbit serum and swine 
anti-rabbit peroxidase (DAKO), diluted 1/100, for 
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TABLE I. Antibodies Used 
Antibody Antigen [ref.] Source Dilution Supplier 
NCL-5D3 
RGE53 
RKSE60 
RCK103 
a-PSAP 
F39.4 
1 I44 
Mon-3001-5 
PVI 
Keratins 8, 18 & 19 
Keratin 18 
Keratin 10 
Keratin 5 
Prostate specific acid phosphatase 
Androgen receptor [29] 
a-smooth muscle actin 
Desmin 
Vimentin [30] 
acinary epithelium (261 
luminal cells [17] 
squamous epithelium [21] 
basal cells [27] 
prostatic glandular epithelium [28] 
smooth muscle cells [23] 
muscle cells [supplier] 
Mouse” 
Mousea 
Mouse“ 
Mouse” 
Rabbitb 
Mouse” 
Mouse” 
Mouse” 
Rabbitb 
1/10 
1/10 
1/10 
1/5 
1/1,000 
1110,000 
1/60,000 
1/15 
1/15 
Euro-Diagnostica (Apeldoorn, NL) 
Euro-Diagnostica 
Euro-Diagnostica 
Dr. F.C.S. Ramaekers, Dept. of Pathology, 
University of Maastricht (Maastricht, NL) 
Dept. of Pathology, Erasmus University 
(Rotterdam, NL) 
Dept. of Pathology, Erasmus University 
Sigma (St Louis, MO) 
Sanbio (Uden, NL) 
Euro-Diagnostica 
”Monoclonal antibody 
bI‘olyclonal antibody. 
monoclonal and polyclonal antibodies, respectively. 
All dilutions of sera or antibodies were prepared with 
PBS (pH 7.2), except for polyclonal antibodies, which 
were diluted in PBS containing 5% bovine serum al- 
bumin (BSA). The peroxidase activity was visualized 
by DAB and hydrogen peroxide. All samples were 
counterstained with Mayer’s hematoxylin. 
Cell Counts 
Scoring of positively stained cells was done by one 
investigator, at 100 x magnification. At least 500 cells 
were counted per sample. Differences between 
groups were considered statistically significant if a P 
value 50.05 was found using the Wilcoxon rank test 
(Mann-Whitney). 
RESULTS 
Explant cultures of prostatic tissue gave rise to an 
initial halo of epithelial cells within a few days. After 
approximately 1 week, the first strands of fibroblastic 
cells could be seen growing out of the tissue blocks. 
During the following weeks, epithelial cells became 
increasingly overgrown by stromal cells. Subcultur- 
ing after trypsinization appeared to promote stromal 
cell growth and to reduce epithelial cell contamina- 
tion. At low density the stromal cells had a flattened, 
irregular polygonal appearance, while at confluent 
culture they showed a more spindlelike morphology 
and formed dense aggregates of elongated cells into 
fan-shaped bundles (Fig. 1). No morphological differ- 
ences were observed between cultures derived from 
malignant and nonmalignant lesions. Doubling times 
of the established stromal cell strains varied between 
2 and 4 days. 
In order to assess the extent of epithelial contam- 
ination of stromal cell cultures, epithelium-specific 
antibodies were applied to cytospin preparations and 
to cultures grown on glass slides. After three or more 
passages, prostate specific acid phosphatase, a 
marker of glandular epithelium known to be ex- 
pressed in vitro [16], was not detectable in our cul- 
tures (Table 11). Similarly, no androgen receptor (AR)- 
positive cells were detected, even though in BPH 
tissue sections some of the stromal cell nuclei reacted 
with the AR-specific antibody (not shown). Since ep- 
ithelial cells are known to express keratins as well 
during in vitro culture, keratin antibodies have been 
used to evaluate prostatic epithelial cell cultures de- 
rived from human tissues [15,16]. To confirm that the 
ratio of epithelialhtromal cells shifts in favor of the 
stromal cells with increasing culture time, primary 
cultures were harvested after 1 week when the initial 
outgrowth of solely epithelial-like cells was seen (PA 
555 = positive control), other cultures were tryp- 
sinized after several weeks, giving the fibroblasts 
enough time to crowd out the epithelial cells (PA 544, 
PA 546, PC 302, PC 303 = negative controls). The 
remaining cultures shown in Figure 2 were tryp- 
sinized after an intermediate period of time; both fi- 
broblasts and epithelial cells were recognized by 
phase contrast microscopy. Cytospins prepared from 
the cultures were stained with the NCL-5D3 anti- 
body, which is specific for keratins of glandular epi- 
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thelium. As a result, only a small fraction (1.0-4.2%) 
of the cells from long-term primary cultures showed 
a positive reaction with the NCL-5D3 antibody, 
whereas in early stage PA 555 (positive control) more 
than 98% of the cells were keratin positive (Fig. 2). 
Primary cultures that were scored after 2-3 weeks 
showed intermediate levels of epithelial cell contam- 
ination. However, at subculture the epithelial cell 
number rapidly decreased, as illustrated by culture 
PC 313 in Figure 3. To exclude the possibility that 
epithelial cells had escaped identification due to a 
change in chain-specific cytokeratin expression dur- 
ing in vitro growth, other keratin-specific antibodies 
were applied as well. As no staining was detected 
with these antibodies (Table II)/ it became unlikely 
that morphologically atypical basal cells reactive with 
RCK103 or cells with squamous metaplasia reactive 
with RKSE60 were present. 
All six stromal cell strains tested, as well as control 
cultures of skin fibroblasts, were strongly stained by 
vimentin antibody (Table 11). Cytospin preparations 
of four more carcinoma-derived and four BPH-de- 
rived cultures also contained over 95% vimentin-pos- 
itive cells. Cytospins of the keratin-positive epithelial 
outgrowth of explant PA 555, however, showed sim- 
ilar numbers of cells reacting with vimentin antibod- 
ies. 
Using cells cultured on glass slides, desmin anti- 
bodies stained a fine network of mainly longitudi- 
nally running filaments covering the entire cytoplasm 
in all cell strains (Fig. 4). In cytospin preparations, 
the average number of desmin-containing cells was 
estimated to be 21.5% (median 17.9; S.D. 19.7) for 
carcinoma- and 4.6% (median 1.4; S.D. 7.7) for BPH- 
derived cultures (Fig. 2). This difference in desmin- 
positive cells proved to be statistically significant (P I 
8 p xh 
Desmin 
+ 
P A 
b g 
0 
PC BPH 
* Pc 302.. PA 544' 
PC 3 0 3 - ~  PA 546' 
601 PC 313 PA 565 
40 
20 
.- 
' PC 413  PA 667 
PC 415 A PA 668 
PC 4 2 1  PA 569 
OA 
I 2 
a 
0 '  
PC BPH PA 560 
Fig. 2. lmmunocytochemical detection of keratins (NCL-5D3 an- 
tibody), desmin, and a-smooth muscle actin in cytospins prepared 
from the f irst outgrowth (passage # I )  of stromal cells from ma- 
lignant (PC) and benign (BPH) prostatic tissue specimens in explant 
culture. *Left to  crowd out epithelial cells. Desmin content PC > 
BPH: P 5 0.05 and a-SM actin content PC > BPH: P I 0.01 
(Wilcoxon rank test, n = 13). 
100 
80 
60 
40 
8 20 90 
0 0 
Desmin 
-'-PC 303 
-+PC 313 
1 60 
40 r; a 
a 20 PA 644 
~ + 
PA 646 * 0- . 1 2 1 4 6 6 7  
PDDDDO. n 
Fig. 3. Expression of keratin, desmin, and a-smooth muscle actin 
in stromal cell cultures a t  subsequent passages of in vitro culture. 
*Left to  crowd out epithelial cells. 
0.05) using the Wicoxon rank test. The percentage of 
positively stained cells was relatively constant over 
several passages (Fig. 3). To this end, cell strains were 
maintained in culture up to 6 months. 
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TABLE II. lmmunocytochemical Analyses of Prostatic Stromal Cells Cultured and Fixed on 
Object Slides 
Control 
Antibody 
BPH Skin 
tissue fibroblastsb Stromal cell cultures” 
A: Epithelial markers 
NCL-5D3 Acinary epithelium 
RGE53 Luminal cells 
RKSE60 Squamous epithelium 
RCK103 Basal cells 
a-PSAP Prostate specific acid phosphatase 
F39.4 Androgen receptor 
1A4 a-smooth muscle actin 
Mon-3001-5 Desmin 
PVI Vimentin 
B: Stromal markers 
+‘ 
+ c  
+” 
+ c  
+ c,e 
- 
+”  
+e 
+ e  
+ 
+ 
+ 
’At least four different cell “strains” were tested at passages #2-8. 
brassage number 11-12. 
‘Glandular epithelium. 
dBasal cells. 
eStroma. 
tures the number of positive cells generally declined 
(Fig. 3). 
DISCUSSION 
Fig. 4. lmmunocytochemical staining of desrnin (A) and a- 
smooth muscle actin (B) in prostatic stromal cells cultured on 
object slides a t  low density. Magnification 400 x . 
The 1A4 antibody, directed against a-smooth mus- 
cle (SM) actin, stained more coarse longitudinal fibril- 
lar structures in the cytoplasm (Fig. 4). In primary 
cultures, the average number of positive cells in car- 
cinoma-derived cultures (mean 75%; median 73.6; 
S.D. 7.4) was significantly larger ( P  5 0.01) than the 
number in BPH-derived stromal cell cultures (mean 
25.6%; median 21.0; S.D. 15.8). These differences, 
however, were only manifest during early passages. 
At higher passage numbers, the percentage of a-SM 
actin-positive cells in BPH-derived stromal cell cul- 
tures increased, whereas in carcinoma-derived cul- 
The results presented in this paper show the rela- 
tive ease with which stromal cell cultures can be ob- 
tained from prostatic tissue explants. After a few 
weeks, the rich culture medium selectively stimulates 
stromal cell proliferation and gives rise to an over- 
growth of these cells at the cost of the initially ap- 
pearing epithelial cells. As determined by immuno- 
cytochemical analysis of keratins in cytospins, such 
stromal cell outgrowths contained less than 5% epi- 
thelial cells during the first passage. Usually this low 
number of contaminating epithelial cells decreased 
even further in subsequent subcultures (Fig. 3). In 
fact, epithelial cells were not detected by microscopy 
or cytokeratin staining after the second passage. 
Needless to say, the epithelial cell content of the first 
harvest depends on the time spent waiting for the 
stromal cells to crowd out the epithelial cells (see also 
Fig. 2). Since trypsinization and subcultivation in our 
hands appeared to be selective in favor of the stromal 
cell population, subcultures were usually initiated at 
an early stage. 
Mesenchymal cells are known to express vimentin 
as intermediate-sized filament protein [ 18-22]. How- 
ever, it was shown by others that nonmesenchymal 
cells can also express vimentin in vitro culture [31]. 
Since we experienced this to be true for our primary 
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cultures of prostatic epithelium (PA 555: 98% keratin- 
positive as well as 95% vimentin-positive cells), the 
results obtained with anti-vimentin antibodies are of 
limited value for the characterization of cultured pro- 
static (stromal) cells. 
Fibroblastic cells, though traditionally considered 
to have a relatively common morphology in culture, 
are endowed with multiple functional properties; 
they play an essential role in the synthesis and reg- 
ulation of extracellular matrix components, contrib- 
ute to wound healing, and are involved in the patho- 
genesis of fibrotic processes [32] and probably in 
neoplasia [33]. Characterization of intermediate fila- 
ment proteins and contractile proteins has shown to 
be a useful approach in differentiating fibroblastic 
phenotypes [23,34]. Defined subtypes have been 
found to express both vimentin and desmin, suggest- 
ing that some stromal cells are equipped with mus- 
cular elements and might participate in wound clo- 
sure and visceral contraction [35,36]. For example, 
immunohistochemical studies have revealed that 
some testicular stromal cells have muscular pheno- 
typic features, supporting the assumption that these 
myoid cells might influence the migration of sperm 
[35]. Recently, a remarkable morphological and func- 
tional similarity was demonstrated between these rat 
testes-derived peritubular cells, and rat prostatic 
stromal cells in culture [7]. Furthermore, the deter- 
mination of cytoskeletal proteins in stromal cells as- 
sociated with pathologic conditions has revealed a 
spectrum of phenotypes that have not yet been found 
in normal tissues [37]. On one hand, these findings 
support the possibility that certain epithelial neopla- 
sias affect the growth and differentiation of fibro- 
blasts present in their immediate vicinity. Fibroblasts 
associated with lung, breast, and colon carcinomas, 
for example, have been shown to express a-SM actin 
[24]. These tumor-associated myofibroblasts are 
thought to be responsible for the desmoplastic re- 
sponse to neoplasias [24,38]. On the other hand, des- 
moplasia has been considered to arise in early stages 
of tumorigenesis [24]. This led to the search for mes- 
enchymal cells with smooth muscle cell differentia- 
tion features in relation to epithelial proliferations, 
thought to predispose to malignant transformation. 
Cytoskeletal analysis of specimens from colon, 
breast, and uterus, indeed, has revealed that the 
presence of a-SM actin-expressing mesenchymal 
cells may be a feature of premalignant lesions or in- 
traepithelial neoplasia [37]. A prominent role of the 
stroma in the pathogenesis of BPH nodules in the 
human prostate was proposed by McNeal more than 
a decade ago [39]. Obviously, the immunocytochem- 
ical observations reported here carry great potential 
diagnostic and prognostic significance: If similar 
changes were to be reflected in vitro, this would pro- 
vide us with a potential tool for studying these 
(pathologic) phenotypes in detail. 
When we focus on our results regarding the initial 
outgrowth of the explants, a striking difference is no- 
ticed between cultures derived from BPH and pros- 
tatic carcinoma. Whereas BPH-derived stromal cell 
cultures predominantly consisted of fibroblastic cells, 
stromal cells derived from malignant lesions showed 
smooth muscle differentiation, as was clearly demon- 
strated by the presence of smooth muscle a-actin pro- 
tein in approximately 75% of the cells (Fig. 2). This 
conclusion was further substantiated by the observa- 
tion that these cultures also contained relatively high 
numbers of desmin-positive cells (25%) compared to 
BPH-derived cultures (<5%). The observation that a 
substantially lower number of cells stained for 
desmin than for a-SM actin is in agreement with find- 
ings reported by Shapiro et al. [40]. These authors 
showed that the percent area density of actin-positive 
tissue in prostate biopsies was twice as large as the 
area density of the anti-desmin-stained tissue com- 
partment, which led to the authors’ conclusion that 
anti-desmin appears to underestimate the amount of 
prostate smooth muscle. 
Immunocytochemical evaluation of serial passages 
revealed that in BPH-derived cultures, increasing 
numbers of cells stained positive for a-SM actin, 
whereas some of the carcinoma-derived cells became 
a-SM actin negative, resulting in a more even distri- 
bution of phenotypic markers in both culture types 
(Fig. 3). One carcinoma-derived culture, however, re- 
tained a high level of a-SM actin expression during all 
seven passages tested. The pathological classification 
of the parental tumor did not provide any clues as to 
why these cells were able to maintain this highly dif- 
ferentiated state under circumstances in which most 
cell types show a tendency to dedifferentiate to a 
state bearing more general mesenchymal properties 
[41]. The shift in phenotype observed in our experi- 
ments might be due to the separation of stromal cells 
from the epithelium (which was still present inside 
the tissue explants) as a result of subculture. How- 
ever, it is also possible that the changes observed 
were caused by extended cultivation, as has been de- 
scribed by several authors [19,42,43]. On one hand, it 
has been shown that a-SM actin-negative fibroblasts 
from breast tissue undergo smooth muscle differen- 
tiation after 4 days of cultivation [38]. On the other 
hand, vascular smooth muscle cells were shown to 
downregulate a-SM actin and thereby resemble my- 
ofibroblasts [44], as might have been the case in our 
cultures. It is therefore important to take into consid- 
eration in future in vitro studies that apparent fibro- 
blasts may represent modulated smooth muscle cells 
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[44]. In this respect it is interesting that cultured lens 
cells gradually develop a-SM actin, despite the fact 
that they do not contain this protein in vivo [24]. 
However, a s  the difference in phenotypes between 
BPH and carcinoma-derived cultures may gradually 
fade a t  subculture, it should be recommended to 
carry out  (coculture) experiments with stromal cells 
from the earliest passage possible. 
In conclusion, cultured h u m a n  prostatic stromal 
cells are heterogeneous with regard to  their differen- 
tiation markers. Two contrasting phenotypes, one ex- 
hibiting fibroblastic features and the other showing 
varying degrees of smooth muscle differentiation, 
were detected in  primary cultures derived from le- 
sions with clinically different behavior. The out- 
growth of different cell populations under  similar 
culture conditions is indicative of a remarkable diver- 
gence in the  stromal-epithelial relationship between 
these two pathological conditions and may provide 
us with a n  excellent tool for studying these processes. 
The reciprocal interaction of these stromal cells with 
normal epithelium, for instance, tested in coculture 
experiments, might help us unravel the complex 
mechanisms leading to  benign a n d  malignant neopla- 
sia . 
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